Skip to main content
. 2019;20(1):255–262. doi: 10.31557/APJCP.2019.20.1.255

Table 2.

General Clinical Characteristics of the BOTPs and the OCPs

BOTPs, No (%) OCPs, No (%)
Histology
 Serous 35 (100%)
 Other 20 (100%)
FIGO (2013) staging
 I-II 16 (80%)
 IIIB 4 (20) 5 (14%)
 IIIC 30 (86%)
Tumor Grade
 High-grade 35(100%)
 Not specify 20 (100%)
BRCA status
 Negative 35 (100%)
 Not specify 20 (100%)
Total no. of patients 20 (100%) 35 (100%)